Sinopharm
1099.HK
#2269
Rank
โ‚น721.94 B
Marketcap
โ‚น231.35
Share price
-1.57%
Change (1 day)
4.69%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.195 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.195 Trillion. In 2024 the company made a revenue of โ‚น7.195 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.582 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.195 T-5.1%
2023โ‚น7.582 T5.42%
2022โ‚น7.192 T-2.1%
2021โ‚น7.346 T16.85%
2020โ‚น6.286 T14.95%
2019โ‚น5.469 T21.52%
2018โ‚น4.500 T5.93%
2017โ‚น4.248 T27.22%
2016โ‚น3.339 T5.37%
2015โ‚น3.169 T9.14%
2014โ‚น2.903 T17.22%
2013โ‚น2.477 T25.94%
2012โ‚น1.966 T34.61%
2011โ‚น1.461 T55.34%
2010โ‚น940.62 B35.79%
2009โ‚น692.71 B37.56%
2008โ‚น503.58 B31.43%
2007โ‚น383.16 B40.26%
2006โ‚น273.18 B